S&P 500   3,122.03 (+0.00%)
DOW   27,936.51 (-0.36%)
QQQ   203.50 (+0.21%)
BABA   184.20 (-0.22%)
T   38.11 (-3.84%)
ACB   2.43 (+6.59%)
F   8.90 (-0.56%)
BAC   32.93 (-0.12%)
DIS   148.41 (+0.51%)
S&P 500   3,122.03 (+0.00%)
DOW   27,936.51 (-0.36%)
QQQ   203.50 (+0.21%)
BABA   184.20 (-0.22%)
T   38.11 (-3.84%)
ACB   2.43 (+6.59%)
F   8.90 (-0.56%)
BAC   32.93 (-0.12%)
DIS   148.41 (+0.51%)
S&P 500   3,122.03 (+0.00%)
DOW   27,936.51 (-0.36%)
QQQ   203.50 (+0.21%)
BABA   184.20 (-0.22%)
T   38.11 (-3.84%)
ACB   2.43 (+6.59%)
F   8.90 (-0.56%)
BAC   32.93 (-0.12%)
DIS   148.41 (+0.51%)
S&P 500   3,122.03 (+0.00%)
DOW   27,936.51 (-0.36%)
QQQ   203.50 (+0.21%)
BABA   184.20 (-0.22%)
T   38.11 (-3.84%)
ACB   2.43 (+6.59%)
F   8.90 (-0.56%)
BAC   32.93 (-0.12%)
DIS   148.41 (+0.51%)
Log in

McKesson Stock Price, Forecast & Analysis (NYSE:MCK)

+0.68 (+0.45 %)
(As of 11/19/2019 03:03 PM ET)
Today's Range
Now: $150.27
50-Day Range
MA: $140.31
52-Week Range
Now: $150.27
Volume30,137 shs
Average Volume1.75 million shs
Market Capitalization$27.08 billion
P/E Ratio11.07
Dividend Yield1.11%
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. Read More…

Industry, Sector and Symbol

Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors



Sales & Book Value

Annual Sales$214.32 billion
Cash Flow$30.11 per share
Book Value$43.20 per share


Net Income$34 million


Market Cap$27.08 billion
Next Earnings Date1/30/2020 (Estimated)

Receive MCK News and Ratings via Email

Sign-up to receive the latest news and ratings for MCK and its competitors with MarketBeat's FREE daily newsletter.

McKesson (NYSE:MCK) Frequently Asked Questions

What is McKesson's stock symbol?

McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

How often does McKesson pay dividends? What is the dividend yield for McKesson?

McKesson declared a quarterly dividend on Wednesday, October 23rd. Investors of record on Monday, December 2nd will be given a dividend of $0.41 per share on Thursday, January 2nd. This represents a $1.64 dividend on an annualized basis and a yield of 1.09%. The ex-dividend date of this dividend is Friday, November 29th. View McKesson's Dividend History.

How were McKesson's earnings last quarter?

McKesson Co. (NYSE:MCK) posted its quarterly earnings data on Wednesday, October, 30th. The company reported $3.60 earnings per share for the quarter, meeting the consensus estimate of $3.60. The firm had revenue of $57.62 billion for the quarter, compared to analyst estimates of $55.06 billion. McKesson had a positive return on equity of 32.77% and a negative net margin of 0.29%. The business's revenue was up 8.6% compared to the same quarter last year. During the same period in the prior year, the company earned $3.60 earnings per share. View McKesson's Earnings History.

When is McKesson's next earnings date?

McKesson is scheduled to release their next quarterly earnings announcement on Thursday, January 30th 2020. View Earnings Estimates for McKesson.

What guidance has McKesson issued on next quarter's earnings?

McKesson updated its FY20 earnings guidance on Wednesday, October, 30th. The company provided earnings per share guidance of $14.00-14.60 for the period, compared to the Thomson Reuters consensus estimate of $14.38.

What price target have analysts set for MCK?

9 equities research analysts have issued twelve-month price objectives for McKesson's shares. Their forecasts range from $130.00 to $164.00. On average, they anticipate McKesson's stock price to reach $146.63 in the next year. This suggests that the stock has a possible downside of 2.4%. View Analyst Price Targets for McKesson.

What is the consensus analysts' recommendation for McKesson?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 7 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for McKesson.

Has McKesson been receiving favorable news coverage?

Headlines about MCK stock have trended somewhat positive recently, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. McKesson earned a coverage optimism score of 1.1 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 1.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for McKesson.

Are investors shorting McKesson?

McKesson saw a drop in short interest in October. As of October 31st, there was short interest totalling 4,110,000 shares, a drop of 13.3% from the September 30th total of 4,740,000 shares. Based on an average daily volume of 1,720,000 shares, the short-interest ratio is presently 2.4 days. Currently, 2.3% of the company's shares are short sold. View McKesson's Current Options Chain.

Who are some of McKesson's key competitors?

What other stocks do shareholders of McKesson own?

Based on aggregate information from My MarketBeat watchlists, some companies that other McKesson investors own include Walt Disney (DIS), Allergan (AGN), Gilead Sciences (GILD), CVS Health (CVS), Johnson & Johnson (JNJ), UnitedHealth Group (UNH), Bank of America (BAC), Boeing (BA), salesforce.com (crm) and Intel (INTC).

Who are McKesson's key executives?

McKesson's management team includes the folowing people:
  • Mr. John H. Hammergren, Chairman & CEO (Age 60)
  • Britt J. Vitalone, CFO & Exec. VP (Age 50)
  • Ms. Lori A. Schechter, Chief Compliance Officer, Exec. VP & Gen. Counsel (Age 57)
  • Mr. Jorge L. Figueredo, Exec. VP & Chief HR Officer (Age 58)
  • Mr. Bansi Nagji, Exec. VP and Chief Strategy & Bus. Devel. Officer (Age 54)

Who are McKesson's major shareholders?

McKesson's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Massachusetts Financial Services Co. MA (3.37%), Sumitomo Mitsui Trust Holdings Inc. (0.42%), River & Mercantile Asset Management LLP (0.31%), Great West Life Assurance Co. Can (0.29%), PGGM Investments (0.28%) and California Public Employees Retirement System (0.26%). Company insiders that own McKesson stock include Brian S Tyler, Brian Scott Tyler, Britt J Vitalone, Erin M Lampert, John H Hammergren, Lori A Schechter, M Christine Jacobs, N Anthony Coles and Sundeep G Reddy. View Institutional Ownership Trends for McKesson.

Which major investors are selling McKesson stock?

MCK stock was sold by a variety of institutional investors in the last quarter, including Anchor Capital Advisors LLC, Virginia Retirement Systems ET AL, Artemis Investment Management LLP, Wedge Capital Management L L P NC, Great Lakes Advisors LLC, CWM LLC, First Interstate Bank and Keybank National Association OH. Company insiders that have sold McKesson company stock in the last year include Brian S Tyler, Brian Scott Tyler, Britt J Vitalone, Lori A Schechter, M Christine Jacobs and Sundeep G Reddy. View Insider Buying and Selling for McKesson.

Which major investors are buying McKesson stock?

MCK stock was purchased by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, PGGM Investments, Signature Estate & Investment Advisors LLC, First Trust Advisors LP, Assenagon Asset Management S.A., Railway Pension Investments Ltd, Robeco Institutional Asset Management B.V. and QV Investors Inc.. View Insider Buying and Selling for McKesson.

How do I buy shares of McKesson?

Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is McKesson's stock price today?

One share of MCK stock can currently be purchased for approximately $150.28.

How big of a company is McKesson?

McKesson has a market capitalization of $27.08 billion and generates $214.32 billion in revenue each year. The company earns $34 million in net income (profit) each year or $13.57 on an earnings per share basis. McKesson employs 80,000 workers across the globe.View Additional Information About McKesson.

What is McKesson's official website?

The official website for McKesson is http://www.mckesson.com/.

How can I contact McKesson?

McKesson's mailing address is 6555 STATE HWY 161, IRVING TX, 75039. The company can be reached via phone at 972-446-4800 or via email at [email protected]

MarketBeat Community Rating for McKesson (NYSE MCK)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  818 (Vote Outperform)
Underperform Votes:  502 (Vote Underperform)
Total Votes:  1,320
MarketBeat's community ratings are surveys of what our community members think about McKesson and other stocks. Vote "Outperform" if you believe MCK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MCK will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel